Evidence map›Paper›PMID 41143260›Full record

ArticleData in brief2025

Iso-seq and RNA-seq data from ML-2 acute myeloid leukemia cells overexpressing the ZCCHC10 gene.

Hao Zhou, Jianlin Zhou, Yichong Ning

Abstract read
In one paragraph

Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hao ZhouCollege of Clinical Laboratory, Changsha Medical University, Changsha 410219, Hunan, China.
Jianlin ZhouCollege of Life Science, Hunan Normal University, Changsha 410081, Hunan, China.
Yichong NingCollege of Life Science, Hunan Normal University, Changsha 410081, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ZCCHC10 (zinc finger CCHC-type containing 10) has been shown to play a tumor suppressive role in acute myeloid leukemia (AML), but the underlying mechanism is not clear. Many ZCCHC proteins are involved in RNA metabolism, such as synthesis, splicing and stability of RNA. To investigate the role of ZCCHC10 in RNA metabolism, we performed PacBio single-molecule long-read isoform sequencing (Iso-seq) and Illumina short-read RNA sequencing (RNA-seq) on ML-2 cells stably overexpressing ZCCHC10 (designated ML2T) and stably overexpressing an empty vector (designated ML2C). The Iso-seq data consists of full-length transcripts from ML2T and ML2C and can be used by researchers to identify mRNA isoforms and decipher the events of alternative processing, including alternative transcription initiation, alternative splicing, and alternative polyadenylation. The RNA-seq data provides the transcript profiles from ML2T and ML2C and can be used by researchers to study the effects of overexpression of ZCCHC10 on gene expression. Integrated analysis of RNA-seq and Iso-seq datasets can reveal the impact of ZCCHC10 overexpression on alternative processing in AML.

Indexed as

Alternative processingAlternative splicingRNA sequencingTranscriptomics

Identifiers

PMID41143260
PMCPMC12545814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.